Evidence map›Paper›PMID 42507733›Full record

ArticlePloS one2026

Leveraging free-text clinical records for heart disease classification through structured feature mapping.

Noha Alnazzawi

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Noha AlnazzawiDepartment of Computer Science and Engineering, Yanbu Industrial College, Royal Commission for Jubail and Yanbu, Yanbu, Saudi Arabia.ORCID https://orcid.org/0000-0003-3265-0297

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension and diabetes are major risk factors for heart disease, which remains among the leading causes of morbidity and mortality worldwide. Heart disease includes heart failure, myocardial infarction, stroke, and atherosclerosis. The identification and monitoring of these risk factors are crucial for early intervention and effective management. Machine learning techniques have the potential to improve the management and prevention of heart disease by enabling the automatic detection of risk factors, which in turn can help doctors personalize treatment and facilitate preventive interventions. In this study, heart disease risk factors were automatically extracted using a combination of multimodal data: both unstructured clinical narratives (e.g., the PrevComp corpus) and structured datasets (e.g., the UCI heart disease dataset) were used to predict the presence or absence of heart disease. The classification model is based on the Light Gradient Boosting Machine (LightGBM), a state-of-the-art implementation of the gradient boosting framework that employs tree-based learning algorithms. The developed classification model demonstrated a robust predictive accuracy of 83% for the presence/absence of heart disease, supporting its potential to accurately identify high-risk patients and improve clinical outcomes.

Indexed as

Heart DiseasesAlgorithmsBoosting Machine Learning AlgorithmsClassification AlgorithmsHeart Disease Risk FactorsHumansMachine LearningPrediction AlgorithmsPredictive Learning ModelsRisk Factors

Identifiers

PMID42507733
PMCPMC13405071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.